Form4insider filings, from the source

SEC Form 4 · accession 0001645627-17-000126

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Oct 4, 2017
Accepted (ET)
Oct 10, 2017 · 3:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockOct 4, 2017P2,000$0.0695A23,692,189D
Common StockOct 4, 2017P2,000$0.0682A23,694,189D
Common StockOct 4, 2017P2,000$0.0695A23,696,189D
Common StockOct 4, 2017P2,000$0.0695A23,698,189D
Common StockOct 4, 2017P2,000$0.0704A23,700,189D
Common StockOct 4, 2017P2,000$0.07A23,702,189D
Common StockOct 4, 2017P2,000$0.07A23,704,189D
Common StockOct 4, 2017P3,000$0.068A23,707,189D
Common StockOct 4, 2017P2,000$0.058A23,709,189D
Common StockOct 4, 2017P2,000$0.0585A23,711,189D
Common StockOct 4, 2017P5,000$0.0585A23,716,189D
Common StockOct 4, 2017P2,000$0.0585A23,718,189D
Common StockOct 4, 2017P2,000$0.0585A23,720,189D
Common StockOct 4, 2017P2,000$0.0585A23,722,189D
Common StockOct 4, 2017P2,000$0.058A23,724,189D
Common StockOct 5, 2017P2,000$0.0644A23,726,189D
Common StockOct 5, 2017P2,000$0.064A23,728,189D
Common StockOct 5, 2017P2,000$0.0632A23,730,189D
Common StockOct 5, 2017P3,000$0.062A23,733,189D
Common StockOct 5, 2017P2,000$0.062A23,735,189D
Common StockOct 5, 2017P2,000$0.0629A23,737,189D
Common StockOct 5, 2017P2,000$0.0635A23,739,189D
Common StockOct 5, 2017P2,000$0.0635A23,741,189D
Common StockOct 5, 2017P2,000$0.0635A23,743,189D
Common StockOct 5, 2017P2,000$0.0632A23,745,189D
Common StockOct 6, 2017P2,000$0.0789A23,747,189D
Common StockOct 6, 2017P2,000$0.075A23,749,189D
Common StockOct 6, 2017P2,000$0.0752A23,751,189D

Table II — derivative securities

No Table II lines on this filing.